Public Health | April 18, 2026
Experts endorse low-sodium salt substitutes to cut India’s hypertension burden
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The trial also demonstrated significant improvements across multiple secondary endpoints
Safety was equally impressive. ENV-294 was well tolerated
The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options
The company spotlights micronutrient’s role in immunity, skin and bone health through digital and radio outreach on National Vitamin C Day
Subscribe To Our Newsletter & Stay Updated
